News About: Pharm. Industry


Hanmi Pharm to recruit more 130 jobs in second half

In its globalization vision, Hanmi Pharm plans to hire 130 new and experienced employees by November 6, following its 100 jobs in the first half. Job seeks will apply for five units export, sales, research & devel...

VGX International to set up plasmid research and production facilities in Chonju

VGX International on October 19 unveiled its plan to establish its research and production facilities for plasmid in an industrial complex in Chonju. The production facility at Chonju industrial complex is expected...

Glass Lewis ures Dong-A's foreign shareholders to vote against Kang-Korea Alcohol nominees

Dong-A Pharmaceutical Co. announced on October 19 that Glass Lewis & Co, one of the world's leading independent providers of proxy voting recommendations and corporate governance advisory services, have recommended th...

54% of OTC users suffer heart burn

53.7 percent of those who take OTCs, such as digestives, have suffered from heart burn, according to a recently released survey. The survey of 664 OTC users, conducted by a regional chapter of the Korean Pharmaceut...

Intermittent dosing drives market growth

Although bisphosphonates are the mainstay of osteoporosis treatment, there is potential for new and innovative products to gain market share. Products that offer intermittent dosing schedules are highly desirable i...

Novo Nordisk is eyeing domestic diabetes market

Novo Nordisk Korea is intensifying heated marketing efforts on a new long-acting insulin analogue Levemir (insulin detemir) to strengthen its presence in local diabetes market. Levemir is a long-acting basal insul...

KFDA approves Novartis's osteoporosis drug

Novartis Korea said on October 16 that the Korea Food and Drug Administration has approved its osteoporosis medicine Aclasta (zoledronic acid 5 mg) for treatment of women with postmenopausal osteoporosis. A once-y...

Pharmaceutical firms and pharmacists advised to promote OTCs

Domestic pharmaceutical makers and proprietors of pharmacy should focus on the development of over-the-counter drugs to survive in an era of the Korea-U.S. FTA, Moon Kyun-tae, Vice Chairman of the Korea Pharmaceutical...

Purimed listed in Australian health authority as treatment of depression

Purimed, Korea's biopharmaceutical company, announced on October 17 that its natural product Lotuzol is listed in the Australian Register of Therapeutic Goods (complementary medicine) for the treatment of depression. ...

GCC profits to go to employees

A large proportion of profits in Green Cross Corporation will be offered to all employees in December, largely thanks to the biggest sales of flagship products in September, a senior official said recently. During...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.